Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-003234-16Phase 4Terminated
Phase 4, randomised, double-blind trial of Placebo-COD Research Private Ltd in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Hannover Medical School. Primary endpoint: Treatment failure requiring additional antibiotic therapy. Started Feb 2013; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-003234-16.